Pakistan’s biggest pharma deal in advanced talks: report
Businessman Munis Abdulla to purchase one of OBS Group's pharmaceutical operations for a reported sum of Rs11bn
Pakistan's OBS Group is in advanced talks...
OBS Pakistan amalgamates AGP with AitkenStuart
It is pertinent to mention that rumours had been circulating that OBS Pakistan was going through major restructuring and this acquisition by Searle comes as a surprise for the market.
Trump vows to reduce US drug prices to world’s lowest
WASHINGTON: US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to match the...
Citi Pharma ventures into direct marketing sector
Company aims to improve medicine accessibility and expand globally
Haleon Pakistan targets expansion to 19 countries, aims for 10% export sales share
Haleon plans to boost exports and local manufacturing, with focus on Vietnam, Philippines and local sourcing to reduce import reliance
Pharmaceuticals may turn to Chinese raw material as tensions with India soar
Pakistan has formulated a strategy to deal with any crisis arising out of an embargo on the import of raw material supplied by India...
Fate of Pfizer’s consumer business in spotlight after Merck sells its unit
NEW YORK: With the sale of Merck's consumer healthcare business to Procter & Gamble, the spotlight now shifts to the fate of Pfizer's consumer healthcare unit,...
Oxfam’s damning report puts multinational pharma companies in the dock over tax evasion
Tax Dodgers: In seven developing countries, firms appeared to avoid an estimated $112m in taxes every year
ISLAMABAD: Oxfam International’s damning report confirmed sustained allegations...
CCP approves acquisition of two Japanese pharma products by Hilton Pharma
Proposed transaction entails the acquisition of Methycobal and Myonal including their trademarks
Customs seizes smuggled Indian-origin medicines worth Rs10.3bn in Karachi
Investigation launched against two pharmaceutical companies over illegal drug trade
Citi Pharma gets FDA nod to start exporting nutraceuticals to the United States
The pharmaceutical ingredients manufacturer enters the consumer-facing market in the US with a product the US regulator classifies as food, and not drugs
Pharma industry protests govt’s refusal to increase drug prices
LAHORE: The Ministry of National Health Service Regulations and Coordination on Monday announced that there will be no immediate increase in drug prices prompting...
BF Bioscience, pharma company owned by Ferozsons and Argentinian Bago Group, got a stellar response to its IPO. What lies ahead?Â
The pharma company, which has been exporting to countries like Indonesia, Belarus and Ukraine, saw book building at Rs 77/share and oversubscription of 3.4 times.
In the first quarter after deregulation, pharma sector revenue up by 25%
The increase in revenue is driven mostly by price increases as drug manufacturers can finally raise prices based on business need and rising costs instead of regulatory fiat
DRAP orders immediate recall of substandard veterinary injection
Zaktyl-20 batch found substandard; authorities warn of therapy failure and drug resistance risks
